28 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
19
Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket.
Janssen Pharmaceutical Companies of Johnson & Johnson
49
Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site.
TBA
42
Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.
Johnson & Johnson Pharmaceutical Research and Development
32
Discovery of BI-9787, a potent zwitterionic ketohexokinase inhibitor with oral bioavailability.
Boehringer Ingelheim Pharma GmbH & Co. KG
6
Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes.
Smith, Gambrell & Russell
22
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor.
Eli Lilly
16
Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease.
Tuojie Biotech (Shanghai) Co.
44
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases.
Hefei University of Technology
8
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose.
Pfizer
40
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.
Terns Pharmaceuticals
12
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK).
Pfizer
250
Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto
Arena Pharmaceuticals
200
SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
Shanghai Simr Biotechnology
158
5-membered and bicyclic heterocyclic amides as inhibitors of rock
Bristol Myers Squibb
210
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
Janssen Pharmaceutica
352
Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
Millennium Pharmaceuticals